As a business engaged in the discovery, development and commercialization of medicines for the treatment of human viral and infectious diseases, Idenix Pharmaceuticals, Inc. strives to act in a way that reflects the highest standards of corporate behavior. We are committed to discovering and developing innovative treatments for patients in need and as part of this commitment we have established a compliance program in accordance with federal, state and industry regulations and guidelines.
|Audit Committee Charter||171.1 KB|
|Compensation Commitee||28.1 KB|
|Nominating Committee Charter||35.5 KB|
|Business Ethics||189.7 KB|
|Corporate Governance||130.2 KB|
|shareholder briefcase||investor kit||email alerts||download library||news feeds||Email Page||Print Page||Share this page|
Collect, save and zip multiple files for fast download and email, or bookmark your favorite files for a later visit to the IR website.
Order printed documents to be sent to you by mail, or view a history of the documents you have previously requested.
Fine-tune the emails you receive from Idenix Pharmaceuticals, Inc. with specific SEC filing types, news types, and stock price changes. Choose to receive the closing stock price each day, or a summary of stock prices at the end of the week.
Find exactly the file(s) you need. Send files directly into your Shareholder Briefcase, or download individual files.
Download a synopsis of the most recent content within our IR website.
Subscribe to RSS news feeds to automatically be notified of SEC filings and news releases.
Email this page
Email this page to yourself or a friend.
Print this page
Print a copy of this page for your records.
Search Investor Relations
Use the form below to search the investor relations site.
Provided by eSignal.